284 related articles for article (PubMed ID: 20089532)
1. DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.
Ramsey CP; Tsika E; Ischiropoulos H; Giasson BI
Hum Mol Genet; 2010 Apr; 19(8):1425-37. PubMed ID: 20089532
[TBL] [Abstract][Full Text] [Related]
2. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
[TBL] [Abstract][Full Text] [Related]
3. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.
Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF
Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424
[TBL] [Abstract][Full Text] [Related]
5. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.
Batelli S; Albani D; Rametta R; Polito L; Prato F; Pesaresi M; Negro A; Forloni G
PLoS One; 2008 Apr; 3(4):e1884. PubMed ID: 18382667
[TBL] [Abstract][Full Text] [Related]
6. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
7. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
Emmer KL; Waxman EA; Covy JP; Giasson BI
J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
[TBL] [Abstract][Full Text] [Related]
9. Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.
Lev N; Barhum Y; Ben-Zur T; Melamed E; Steiner I; Offen D
J Mol Neurosci; 2013 Jul; 50(3):542-50. PubMed ID: 23536331
[TBL] [Abstract][Full Text] [Related]
10. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice.
Nguyen TA; Frank-Cannon T; Martinez TN; Ruhn KA; Marvin M; Casey B; Treviño I; Hong JJ; Goldberg MS; Tansey MG
J Neuroinflammation; 2013 Apr; 10():50. PubMed ID: 23622116
[TBL] [Abstract][Full Text] [Related]
11. DJ-1 associates with synaptic membranes.
Usami Y; Hatano T; Imai S; Kubo S; Sato S; Saiki S; Fujioka Y; Ohba Y; Sato F; Funayama M; Eguchi H; Shiba K; Ariga H; Shen J; Hattori N
Neurobiol Dis; 2011 Sep; 43(3):651-62. PubMed ID: 21645620
[TBL] [Abstract][Full Text] [Related]
12. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
[TBL] [Abstract][Full Text] [Related]
13. Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy.
Sargent D; Bétemps D; Drouyer M; Verchere J; Gaillard D; Arsac JN; Lakhdar L; Salvetti A; Baron T
Sci Rep; 2018 Dec; 8(1):17563. PubMed ID: 30510219
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
15. Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.
Behere A; Thörnqvist PO; Winberg S; Ingelsson M; Bergström J; Ekmark-Lewén S
J Neurosci Res; 2021 Oct; 99(10):2525-2539. PubMed ID: 34292621
[TBL] [Abstract][Full Text] [Related]
16. DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia.
Nash Y; Schmukler E; Trudler D; Pinkas-Kramarski R; Frenkel D
J Neurochem; 2017 Dec; 143(5):584-594. PubMed ID: 28921554
[TBL] [Abstract][Full Text] [Related]
17. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
[TBL] [Abstract][Full Text] [Related]
18. Prion-like transmission of α-synuclein pathology in the context of an NFL null background.
Rutherford NJ; Brooks M; Riffe CJ; Gorion KM; Howard JK; Dhillon JS; Giasson BI
Neurosci Lett; 2017 Nov; 661():114-120. PubMed ID: 28964772
[TBL] [Abstract][Full Text] [Related]
19. Models of α-synuclein aggregation in Parkinson's disease.
Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A
Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491
[TBL] [Abstract][Full Text] [Related]
20. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
